Study Reveals Ophthalmic Acid as Potential Alternative to Dopamine for Parkinson’s Treatment

A groundbreaking study from UC Irvine reveals that ophthalmic acid may be a viable alternative to dopamine for regulating motor functions, offering new therapeutic strategies for Parkinson’s disease. Published in the journal Brain, the research shows that ophthalmic acid can reverse motor impairments in mouse models for over 20 hours, challenging the notion that dopamine is the sole neurotransmitter responsible for motor control. This discovery could pave the way for innovative treatments for Parkinson’s and other movement disorders.